To clarify the effect of Spred2 restoration on erythroid differentiation of CML cells, the CML CD34+ cells were transduced with Ad5/F11p-Spred2, and assayed for erythorid differentiation ability. The gene discussed is SPRED2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.